Régions
Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Midi-Pyrénées528
Santiago Perez-Lloret26
Midi-Pyrénées Sauf Santiago Perez-Lloret" 508
Santiago Perez-Lloret Sauf Midi-Pyrénées" 6
Midi-Pyrénées Et Santiago Perez-Lloret 20
Midi-Pyrénées Ou Santiago Perez-Lloret 534
Corpus9014
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000194 Santiago Perez-Lloret [Argentine] ; Olivier Rascol [France]Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.
000636 Olivier Rascol [France] ; Santiago Perez-Lloret [France] ; Philippe Damier [France] ; Arnaud Delval [France] ; Pascal Derkinderen [France] ; Alain Destée [France] ; Wassilios G. Meissner [France] ; Francois Tison [France] ; Laurence Negre-Pages [France]Falls in ambulatory non-demented patients with Parkinson's disease.
000872 Santiago Perez-Lloret ; Laurence Negre-Pages [France] ; Philippe Damier [France] ; Arnaud Delval [France] ; Pascal Derkinderen [France] ; Alain Destée [France] ; Wassilios G. Meissner [France] ; Ludwig Schelosky [Suisse] ; Francois Tison [France] ; Olivier RascolPrevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease.
000B02 Santiago Perez-Lloret [France] ; María Ver Nica Rey [France] ; James Crispo [Canada] ; Daniel Krewski [Canada] ; Marise Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France]Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients
000D29 Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Anne Pavy-Le Traon ; Olivier RascolEmerging drugs for autonomic dysfunction in Parkinson's disease.
000F53 Santiago Perez-Lloret [France, Argentine] ; Maria Veronica Rey [France] ; Pietro Lucca Ratti [France] ; Olivier Rascol [France]Rotigotine transdermal patch for the treatment of Parkinson's Disease
001136 Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Nelly Fabre ; Fabienne Ory ; Umberto Spampinato ; Jean-Michel Senard ; Anne Pavy-Le Traon ; Jean-Louis Montastruc ; Olivier RascolFactors related to orthostatic hypotension in Parkinson's disease.
001154 Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Nelly Fabre ; Fabienne Ory ; Umberto Spampinato ; Jean-Louis Montastruc ; Olivier RascolDo Parkinson's disease patients disclose their adverse events spontaneously?
001325 Olivier Rascol [France] ; Joaquim Ferreira [Portugal] ; Laurence Nègre-Pages [France] ; Santiago Perez-Lloret [France] ; Lucette Lacomblez [France] ; Monique Galitzky [France] ; Jean-Christophe Lemarié [France] ; Jean-Christophe Corvol [France] ; Jonathan M. Brotchie [Canada] ; Laura Bossi [France]A proof‐of‐concept, randomized, placebo‐controlled, multiple cross‐overs (n‐of‐1) study of naftazone in Parkinson’s disease
001430 Santiago Perez-Lloret [France] ; Maria Veronica Rey [France] ; Nelly Fabre [France] ; Fabienne Ory [France] ; Umberto Spampinato [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France]Do Parkinson's disease patients disclose their adverse events spontaneously?
001539 Santiago Perez-Lloret [France] ; Olivier RascolSafety of rasagiline for the treatment of Parkinson's disease.
001545 Santiago Perez-Lloret [France] ; Santiago Perez Lloret ; María Ver Nica Rey ; Luca Ratti ; Olivier RascolPramipexole for the treatment of early Parkinson's disease.
001646 Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
001722 Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Drug‐induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France
001845 Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Drug-Induced Parkinsonism: A Review of 17 Years' Experience in a Regional Pharmacovigilance Center in France
001A44 Santiago Perez-Lloret [France] ; Olivier RascolDopamine receptor agonists for the treatment of early or advanced Parkinson's disease.
001C33 Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database
001D46 Santiago Perez-Lloret [France, Argentine] ; Olivier Rascol [France]Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson's Disease
001E89 Olivier Rascol [France] ; Santiago Perez-LloretRotigotine transdermal delivery for the treatment of Parkinson's disease.
005956 Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Nelly Fabre ; Fabienne Ory ; Umberto Spampinato ; Christine Brefel-Courbon ; Jean-Louis Montastruc ; Olivier RascolPrevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024